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Abstract
Introduction Few data are available about the incidence and
costs of hip fractures in Italy. We aimed to determine the
impact of hip fractures vs. acute myocardial infarction
(AMI).
Methods We studied the national hospitalization database
to calculate their incidence and costs in adults aged ≥45
between 1999 and 2002.
Results In 2002, there were 86,719 hip fractures with a
10.0% increase over 4 years. We observed a predominance
of women (77.1%) and a strong age effect: 92.7% of
patients were ≥65 years old and 80% of fractures occurred
in women aged ≥75, showing a clear relationship with the
incidence of osteoporosis. Hospitalizations due to AMI
after 45 years of age in 1999 were only 9% higher than
those for hip fracture, although this difference increased
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over the 4 examined years up to 24%. Considering the
DRGs costs, hip fractures resulted in being more expensive
than AMI overall and concerning elderly people.
Conclusions This study shows that in the Italian population
aged ≥45, hospitalizations following hip fracture and AMI
between 1999 and 2002 were comparable, while hip
fractures’ direct costs were higher and grew faster than costs
for AMI. Hip fractures in Italy are a serious medical problem
and a leading health-cost driver.
Keywords Aging . AMI . Costs . Epidemiology .
Hip fractures . Incidence
Introduction
Demographic trends of the last 50 years have increased life
expectancy and changed the age profile of populations in
developed countries. Italy has one of the highest life
expectancies in the world: according to the Italian National
Institute for Statistics (ISTAT), life expectancy at birth
increased at a rate of 4 months per year from 1950 to 2002,
reaching 76.2 years for men and 82.6 years for women [1];
life expectancy is estimated to rise to 77.9 and 84.4 years,
respectively, by 2010 [1]. High life expectancy combined
with low natality has increased the weight of older age
groups within the general population, such that Italy
represents an interesting international case study for
aging-related diseases. In Italy, 18% of the population is
actually over 65 years of age; within the next decade, this
age group may exceed 22% of the population [2].
Moreover, 4% of this group is already ≥80 years of age
[1]. Increased life expectancy is associated with a greater
frailty of elderly people and a higher prevalence of chronic
and degenerative diseases. Osteoporosis and its complica-
tions—especially hip fractures—represent a challenge for
health professionals and decision makers in the 21st
century. The World Health Organization (WHO) considers
osteoporosis to be second only to cardiovascular diseases as
a critical health problem [3]. The Epidemiological Study on
the Prevalence of Osteoporosis in Italy (ESOPO) reported a
high prevalence of osteoporosis in 2000: 23% among all
women, with age-specific rates ranging from 9% (40 to
49 year olds) to 45% (70 to 79 year olds), and almost 15%
in men aged ≥60 years [5].
Thus, we estimate that in Italy 4 million women and 800
thousand men are exposed to an increased risk of fracture,
as shown by several studies [6–13]. The International
Osteoporosis Foundation (IOF) estimated that, worldwide,
hip fractures will occur in 18% of women and 6% of men,
while 33% of women and 11% of men aged ≥80 years will
experience a hip fracture due to osteoporosis [3, 4]. Hip
fractures require a longer period of hospitalization than all
other pathologies, with the only exception of psychiatric
diseases [14]. In developed countries, mortality from hip
fractures is greater than that from gastric and pancreatic
cancer; at the same time, the risk of experiencing a hip
fracture is higher than that of developing breast, endome-
trial and ovarian cancer in women or prostatic cancer in
men [3]. The current mortality following hip fractures is
similar to that for breast cancer, with a 5% acute mortality
rate that increases to 15–25% within 1 year [2, 6, 15]. Once
hip fracture has occurred, the ability to walk is completely
lost in 20% of cases, and only 30–40% of patients recover a
degree of autonomy comparable to the period before the
fracture [2, 15–19]. Each year in Italy, almost 18,000
persons become completely disabled as a consequence of
hip fractures, resulting in inestimable human suffering and
substantial social costs [2]. Despite these observations, no
detailed data are available about the incidence and costs of
hip fractures in the elderly Italian population, demonstrating
a worrisome lack of appreciation concerning the severity of
this pathology. Therefore, we carried out a detailed study to
evaluate the impact of hip fractures in Italy in terms of
incidence and costs. Furthermore, our intention was to
perform a comparison analysis with a different pathology
whose severity is well appreciated by healthcare operators
and the public. As comparator, we chose acute myocardial
infarction (AMI) because it can be considered as emblem-
atic for cardiovascular diseases (the worldwide leading
critical health problem according to WHO, as cited above).
Like hip fractures, AMI has multiple risk factors and a high
prevalence among the general population; it is expected to
produce high healthcare costs, and preventive measures
represent a critical issue as for hip fractures.
Materials and methods
We studied the impact of hip fractures, in comparison to
acute myocardial infarction (AMI), in the Italian population
aged 45 years and older, in the 4-year period 1999–2002.
We included persons between 45 and 65 years of age as
well as elderly subjects because we expected the incidence
and costs of AMI to be high in this younger subgroup. The
study period was chosen because it reflects the most
recently available nationwide clinical and demographic
data. Population data were obtained from the National
Institute for Statistics (ISTAT) for each of the considered
years: in 2002, there were 25,055,775 adults ≥45 years of
age [1].
Analysis of epidemiological trends
Clinical data were obtained from the national hospitaliza-
tion database (SDO) maintained by the Italian Ministry of
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Health. National hospitalization records are the best
possible surrogate to reflect the true incidence of hip
fractures in the population. Hip fractures were defined by
the following ICD-9CM diagnosis codes: 820.0–820.1
(femoral head fractures), 820.2–820.3 (inter-trochanteric
femoral fractures) and 820.8–820.9 and 821.1 (other
femoral fractures). AMI was defined by code 410 and all
subcodes. Data on incidence and hospital stay were
stratified by gender and into three age groups (45–64,
65–74 and ≥75 years) and were processed using Stata
(StataCorp, College Station, USA) and Excel (Microsoft,
Redmond, USA) software. We performed descriptive
statistical analyses of the incidence in each gender and
age subgroup across the 4 examined years.
Hospitalization direct costs analysis
Analysis of direct costs was based on the costs ascribed to
diagnosis-related groups (DRGs), according to the Minis-
terial Decree DM 549 of 30 June 1997. This decree
contains the national DRG rate list adopted during the
4 years examined in our study. However, the Italian system
allows each region to drop the DRG value at the local level.
The average reduction adopted is about 15%. Therefore, in
the present analysis, we used the 1997 DRG rates reduced
by 15% in order to be more conservative. DRGs considered
relevant to hip fractures were: 209 (surgical procedures on
major joints and hip replacement), 210–211 (hip and femur
surgery) and 235–236 (hip, femur or pelvis fractures).
Because not all patients assigned these DRGs had a main
diagnosis of hip fracture (i.e., osteoarthritis accounts for a
substantial number of hip replacements), we asked the
Ministry of Health to determine the percentage of costs due
to hip fracture for each DRG. The analysis was performed
for patients living in Lazio (including Rome), a region with
5.3 million inhabitants, an aging index comparable to the
national average [1] and a number of large hospital and
orthopedic centers. The information provided by the
Ministry of Health was consistent with the findings we
obtained on a smaller sample of almost 1 million people
assisted by two local health authorities (Lecce/1 and
Lecce/2). According to this analysis performed by the
Ministry of Health, 30% of costs ascribed to DRG 209 and
80% of costs ascribed to DRGs 210, 211, 235 and 236 were
attributable to a main diagnosis of hip fracture. We
considered these rates to represent the weight of hip
fracture-related costs for each DRG.
Cost analysis for AMI included all DRGs that specified
this pathology: both medical and surgical ones. Medical
DRGs (including costs due to fibrinolysis or thrombolysis)
were the following: DRG 121 (cardiovascular diseases with
AMI and cardiovascular complications, patient alive), DRG
122 (cardiovascular diseases with AMI without cardiovas-
cular complications, patient alive), DRG 123 (cardiovascu-
lar diseases with AMI leading to death) and DRG 124
(cardiovascular diseases with AMI, treated by cardiac
catheterization and leading to complications). All patients
assigned to these medical DRGs presented a main diagnosis
of AMI. Surgical DRGs included in order to consider
percutaneous coronary interventions or coronary bypass
were the following: DRG 107 (by-pass) and DRG 112
(percutaneous interventions/angioplasty). The Ministry of
Health provided us with the percentage of costs resulting
from AMI for the surgical DRGs considered (actually not
all patients assigned these DRGs had a main diagnosis of
AMI, i.e., unstable angina accounts for a substantial
number of these procedures). As previously, this informa-
tion was based on the population of the Lazio region
(including Rome) as a significant sample and was con-
firmed on the smaller sample of 1 million people assisted
by local health authorities Lecce/1 and Lecce/2. This
analysis revealed that only 1% of DRG 107 and 15% of
DRG 112 overall costs were related to a main diagnosis of
AMI. The analysis of direct costs was conducted assuming
that the length of hospitalization for hip fractures and AMI
did not exceed the average values calculated in the DRG
rates. Direct costs were evaluated for all patients (≥45 years
of age), as well as for elderly patients (≥65 years).
Rehabilitation and indirect costs estimation
Although our study intended to focus on hospitalization
costs, because they could be more accurately measured
thanks to the availability of institutional databases (i.e.,
hospitalization records), we have also provided an estima-
tion attempt of rehabilitation costs and indirect costs
following hip fractures and AMI. For elderly patients with
hip fractures, we considered indirect costs associated with
postoperative rehabilitation, disability pensions and over-
head. According to the latest Italian study [23], the average
cost for 1 month of postoperative rehabilitation, after
adjustment and conversion into the new Euro currency, is
estimated to be 5,375 Euros per patient. Actually, the
duration of the rehabilitation period following hip fractures
according to the Italian law is 1 month, including
rehabilitative interventions started during the hospitaliza-
tion (usually the first 10–14 days) and their ambulatorial or
home-based extension. We computed rehabilitation costs
only for 95% of the patients, assuming that 5% die
immediately after the surgical procedure [2, 6, 15]. For
the estimated 18,000 patients who annually become
disabled as a consequence of hip fracture [2], we
considered a government-paid disability financial aid of
6,000 Euros per year, as provided according to the Italian
law for disabled persons, corrected for the average yearly
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mortality rate for hip fractures (15–25%) [2, 6, 15]. The
impact of all the other indirect costs related to hip fractures
were estimated to account for 20% of overall direct costs,
as suggested by the IOF [3].
The average duration of the rehabilitation period
following AMI according to the Italian law is 21 days,
including rehabilitative interventions started during the
hospitalization and their ambulatorial or home-based
extension. To assess rehabilitation costs following AMI,
we have considered the rate fixed by Italian law for
intensive rehabilitation activities (rate corresponding to
code no. 56): 200 Euros per day. We computed rehabilita-
tion costs only for 85% of the patients, assuming a 15%
acute mortality rate following AMI [24, 25]. Diagnosis of
AMI alone (excluding severe complications, defined by
other ICD-9CM diagnosis codes) is usually not considered
by the Italian law as a condition leading to the recognition
of disability financial aid, and it was not the aim of this
study to evaluate costs of AMI complications or those
related to other cardiovascular diseases. Indirect costs
related to AMI are difficult to evaluate, but they could
represent up to the double the overall direct costs [25, 26].
Results
The total number of hip fractures in Italy and the average
hospitalization days among adults ≥45 years of age was
78,834 in 1999 and 86,719 in 2002, corresponding to an
increase of 10.0% over 4 years (Table 1). Considering all
4 years together, the majority of hip fractures occurred in
patients 65 years of age or older (93.1%) and particularly in
women (77.1%). Among women, 79.2% of fractures were
experienced in patients ≥75 years of age. The number of
fractures in this subgroup of women increased by 12.8%
over 4 years and accounted for most (77.0%) of the
observed increase in total hip fractures between 1999 and
2002. In the same period, hip fractures in men aged
≥75 years increased by 16.0% to 13,582. The mean
duration of hospitalization ranged from 14.0 to 16.7 days
for all age and gender categories in each year examined.
These data verified our methodological assumption for the
analysis of costs that the actual hospital stay did not exceed
the allowed values of DRGs. Breakdown by age and gender
(Table 3) confirmed the marked increase with age and the
predominance of women, whose incidence was more than
twice that of men for the two older age groups. The
temporal increase in hip fracture incidence from 1999 to
2002 is evident in the oldest age group (for both genders).
In 2002, the incidence of hip fractures in people aged
75 years and over was 185.0 per 10,000 persons for women
and 84.9 for men.
Tables 2 and 3 show the total number and the average
hospitalization days due to AMI in Italy among adults
≥45 years of age between 1999 and 2002. Table 4 shows
the incidence of AMI per 10,000 inhabitants between 1999
and 2002. In the same Italian population aged ≥45 years,
acute myocardial infarction (AMI) resulted in the hospital-
ization of 86,100 patients in 1999 and 106,842 patients in
2002, corresponding to an increase of 24.0% over 4 years.
The number of hospitalizations due to AMI in men
approximates the number of hospitalizations for hip
fractures in women; therefore, in 1999, AMI resulted only
in 7,266 more hospitalizations than hip fractures (a dif-
ference of 9%); in the years 2000, 2001 and 2002, AMI
resulted in 9,846 (11%), 13,425 (16%) and 20,123 (23%)
additional hospitalizations, respectively, compared to hip
fractures. Considering only elderly persons, direct costs of
hospitalization for hip fractures were >40% higher than
those for AMI in each year analyzed. Overall direct costs for
hip fractures and AMI in the period 1999–2002 were
determined as the sum of the weighted costs for each
DRG. Direct costs for hip fractures increased by 22.3% from
417 to 510 million Euros (Table 5). Elderly people ≥65 years
Table 1 Number of hip fractures and average duration of hospitalization in Italy during 1999–2002, by age and gender
Age group 1999 2000 2001 2002
Men Women Men Women Men Women Men Women
45–64 years
Fractures, n 2,520 3,633 2,527 3,259 2,550 3,584 2,510 3,405
Hospitalization, days 15.4 14.4 14.5 14.4 14.1 14.2 14.2 14.0
65–74 years
Fractures, n 3,573 9,854 3,611 9,589 3,716 9,618 3,715 9,879
Hospitalization, days 16.3 16.2 16.4 16.0 16.0 15.7 16.0 15.3
≥75 years
Fractures, n 11,702 47,552 12,426 47,867 13,153 51,867 13,582 53,628
Hospitalization, days 15.9 16.7 16.0 16.6 15.9 16.2 15.6 15.7
Total fractures, n 17,795 61,039 18,564 60,715 19,419 65,069 19,807 66,912
Average hospitalization days 15.90 15.61 15.87 16.38 15.68 16.01 15.49 15.55
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old accounted for approximately 80% of the total costs for
hip fracture; for these patients, costs increased by 15.5%
over the 4 years. Direct costs for hospitalization following
AMI (Table 5) increased by 2.5% from 400 to 410 million
Euros; in elderly patients, costs increased by 12.0% over
the 4 years. Overall, these data indicate that in the 4 years
examined, the costs associated with hospitalization for hip
fractures were higher and increased faster than costs for AMI.
Although the objective of the study was to determine
incidence and hospitalization costs as the primary endpoint,
we report in Tables 6 and 7 the estimations of other costs
not related to hospitalization. The results of these secondary
analyses may contribute to a full evaluation of costs
generated by hip fractures and AMI, which also requires a
consideration of costs due to rehabilitation, disability
pensions and indirect costs. It should be pointed out that
rehabilitation costs following both hip fractures and AMI
are comparable to those of hospitalization. Therefore, the
analysis of 2002 data for elderly subjects revealed that total
direct and indirect costs for hip fractures in Italy exceeded 1
billion Euros.
Discussion
This study aimed to measure more appropriately the impact
of hip fractures in Italy by analyzing data archived in the
national hospitalization database. Although the national
hospitalization records represent the best possible surrogate
of the true incidence, a very small number of hip fractures
may not result in hospitalization. It is important to point out
the assumption that all hip fractures were considered in this
analysis, independently of underlying osteoporosis or not;
no osteoporosis attribution rates were applied, and it was
impossible to exclude readmissions for a same person.
However, the most frequent underlying cause of hip
fractures in the elderly (which represent the majority of
cases recorded in the hospitalization database) is osteopo-
rosis. As expected, 79.2% of fractures were experienced in
patients 75 years of age or older, in accordance with the
higher prevalence of osteoporosis in this age class [5].
Compared to acute myocardial infarction, the number of
hospitalizations for hip fracture was 9% less in 1999 and
23% less in 2002; this change is partially due to the 24.0%
increase in hospitalizations for AMI, attributable not only to
a greater incidence, but also to the establishment throughout
Table 3 Incidence of hip fractures per 10,000 inhabitants in Italy (1999–2002), stratified by gender and age class
1999 2000 2001 2002
Men Women Men Women Men Women Men Women
45–64 years 3.6 4.9 3.7 4.5 3.2 4.9 3.5 4.7
Growth vs. prior year +2.8% −8.2% −13.5% +8.9% +9.4% −4.1%
65–74 years 13.6 30.1 13.9 29.8 14.2 29.7 14.2 30.4
Growth vs. prior year +2.2% −1.0% +2.2% −0.3% 0.0% +2.4%
≥75 years 72.8 163.9 77.9 165.8 82.2 178.9 84.9 185.0
Growth vs. prior year +7.0% +1.2% +5.5% +7.9% +3.3% +3.4%
Table 2 Number of AMI and average duration of hospitalization in Italy during 1999–2002, by age and gender
Age group 1999 2000 2001 2002
Men Women Men Women Men Women Men Women
45–64 years
AMI, n 25,220 4,646 25,357 4,765 27,359 5,279 28,594 5,673
Hospitalization, days 8.95 9.53 8.55 9.12 8.15 8.72 7.63 8.26
65–74 years
AMI, n 17,519 7,838 17,996 7,925 18,909 8,637 20,109 9,149
Hospitalization, days 9.70 9.82 9.31 9.43 9.29 9.73 8.80 9.44
≥75 years
AMI, n 14,830 16,047 15,917 17,195 18,234 19,495 20,804 22,513
Hospitalization, days 10.52 10.83 10.18 10.51 9.82 10.31 9.62 10.17
Total AMI, n 57,569 28,531 59,240 29,885 64,502 33,411 69,507 37,335
Average hospitalization days 9.58 10.34 9.22 10.00 8.95 9.90 8.56 9.69
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the country (in the year 2000) of an effective emergency
service capable of preventing many of the acute deaths that
previously occurred before the hospital admission. Direct
costs of hospitalization following hip fracture were higher
than those for AMI and increased at a greater rate over the
4 years examined. This is easily explained because most of
the DRGs considered for AMI represent medical DRGs
(including fibrinolysis), which cost much less than surgical
DRGs. Surgical DRGs related to AMI (i.e., PCI, BCGA,
etc.) were fewer than those for hip fractures (always
requiring surgical procedures). Concerning AMI, the
number of patients hospitalized is lower than the real
incidence because sudden mortality is expected to be quite
relevant. However, this study was focused on hip fractures,
and AMI was studied in comparison as a pathology whose
severity is generally well perceived. It was not our aim to
determine the incidence of AMI in the general population,
including sudden deaths, which do not lead to hospitaliza-
tion; however, this could not have caused an underestima-
tion of the number of hospitalizations and the direct cost
analysis. Other cardiovascular ischemic diseases, such as
unstable angina pectoris, were not included in the analysis
because they are classified in different ICD9CM codes and
also because they frequently require ambulatory treatment,
which is not the object of this analysis. However, although
direct costs of hospitalization due to hip fractures are higher
than those of AMI, the overall costs of the two pathologies
(if considering rehabilitation costs and indirect costs) may
be comparable as described in Tables 6 and 7.
Our findings seem to be consistent with IOF estimates of
the overall incidence and costs of hip fractures in Italy [3]
and provides further detailed information regarding the
costs specifically generated by elderly people. Furthermore,
our findings are consistent with the national hospitalization
database analysis concerning surgical aspects (the number
of operations due to hip fractures) [27] and with data from
other European countries [28–31] and from the United
States [32–34], confirming the high social impact of hip
fractures despite a worrisome lack in the perception of its
severity [35]. Compared to our estimate of 1 billion Euros
in Italy, the reported costs of osteoporotic fractures in other
countries are (in US dollars) 2 billion for Canada and
Australia [3, 34, 36], 31 billion in the United States [3, 32]
and 17 billion in EU countries [3]. This Italian study is of
special interest because it has been carried out using the
national hospitalization database; thus, the data reported are
more detailed values rather than simple estimates. Accord-
ing to the commonly accepted approach in health econom-
ics, we used DRGs in calculating direct costs because this
permitted us to measure the financial consequences of
hospitalization. However, the Italian DRG system has
changed since the last national law of 1997, and now the
Table 4 Incidence of AMI per 10,000 inhabitants in Italy (1999–2002), stratified by gender and age class
1999 2000 2001 2002
Men Women Men Women Men Women Men Women
45–64 years 35.70 6.30 35.90 6.47 38.73 7.16 40.48 7.70
Growth vs. prior year +0.6% +2.7% +7.9% +10.7% +4.5% +7.5%
65–74 years 66.85 24.16 68.67 24.43 72.15 26.62 76.73 28.20
Growth vs. prior year +2.7% +1.1% +5.1% +9.0% +6.3% +5.9%
≥75 years 92.65 55.35 99.44 59.31 113.92 67.25 129.98 77.66
Growth vs. prior year +7.3% +7.2% +14.6% +13.4% +14.1% +15.5%
Table 5 Total direct costs of hospitalization for hip fractures and acute myocardial infarction (AMI excluding unstable angina pectoris), 1999–
2002, for all adults (≥45 years) and for the elderly (≥65 years). Values are expressed in millions of Euros
Adults Relative growth difference
between hip fr. and AMI
Elderly Relative growth difference
between hip fr. and AMI
Hip fracture AMI Hip fracture AMI
1999 417 400 341 241
2000 442 402 343 243
Growth vs. previous year +6.0% +0.5% +5.5% +0.6% +0.8% −0.2%
2001 480 408 373 251
Growth vs. previous year +8.6% +1.5% +7.1% +8.7% +3.3% +5.4%
2002 510 410 394 270
Growth vs. previous year +6.3% +0.5% +5.8% +5.6% +7.6% −2.0%
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20 regions may establish their own rates, cutting off the
DRGs values at the local level. Accepting a 15% average
reduction for each DRG allowed us to estimate a mean
value in order to overcome the differences between the
regions. The costs of rehabilitation in this study may be
underestimated. We chose to consider only 1 month of
postoperative rehabilitation because this is the average
duration provided by the law, including the rehabilitative
interventions performed at the hospital (usually 10–
14 days of postoperative hospitalization days), even
though not all patients comply with the rehabilitation
program afterwards [37]. As suggested by the IOF [3], we
considered that indirect costs due to overhead equalled 20%
of the overall direct costs, even though many authors have
suggested that these costs are higher than hospitalization
costs [28, 30, 33, 34]. Finally, we estimated the cost for
disability financial aid paid by the state to persons who
become fully disabled (recognition of disability ≥75%)
after hip fracture, taking in account that some of them
(15%–25%) die within a year [2, 6, 15]. The cost estimates
related to disability pensions following hip fractures are
conservative: actually the entire annual sum paid as social
aid may exceed 7,500 Euros per patient. We also have to
consider that although the Italian law does not provide
financial aid to people who have experienced AMI, its
potential complications such as chronic hearth failure
may result in the acknowledgment of a disability pension
(but only if the disease is very severe, because of the
adoption of more conservative criteria by the health
authorities concerning cardiovascular diseases).
A complete analysis of the phenomenon would also
require data regarding intangible costs associated with hip
fractures, such as costs due to pain, lack of productivity,
premature mortality, a reduction in the quality of life and
social suffering. An Italian analysis reviewed by the Italian
Senate Health Commission in 2002 [2] indicated that
patients and their relatives lose 364,000 working days per
year because of hip fractures, resulting in a high economic
impact estimated as 1.7 billion Euros. Like rehabilitation
costs and indirect costs, intangible costs are also difficult to
measure and were not the aim of this study; therefore, they
were not assessed. The increasing incidence of hip fracture
is ascribed mainly to elderly women, in accordance with the
higher prevalence of osteoporosis in the oldest age groups.
This study reveals the urgent necessity of adopting
preventive measures to reduce the incidence and costs of
osteoporosis-related hip fractures, which continue to be
considered as a secondary health problem. Although our
data have demonstrated similar incidences and costs
between hip fractures and AMI in Italy, the overall Italian
expenditures for pharmacological treatments aimed to
reduce the risk of hip fractures in 2001 represented just
0.29% (almost 46 million Euros) of the national drug
expenditures [2]. In the same year, total expenditures for
cardiovascular drugs represented 32% of the total [2]. Other
measures to prevent hip fractures could be the promotion of
healthy lifestyles and physical activity and the use of hip
protectors [38–44]. Further studies, including pharmaeco-
nomic simulations, should determine if the adoption of
proper preventive measures (not exclusively pharmacolog-
ical ones) in high-risk patients (i.e., people with previous
vertebral fractures and patients taking corticosteroid drugs)
can decrease the incidence of hip fractures without a major
impact on general costs. In Sweden, economic simulations
[45] have already documented that fracture-preventive
treatments are more cost-effective than common cardiovas-
cular preventive strategies (e.g., treating hypertension for
the prevention of stroke). Ethical considerations about the
right of elderly people to live with an adequate quality of
life make it urgent to find appropriate answers to aging-
related health problems like hip fractures, which are
increasing year by year in developed countries.
Table 7 Overall estimated costs for the 72,575 AMI registered in
Italian elderly persons (≥65 years of age) in 2002
Patients, n Unit cost,
Euros
Cost
Hospitalization costs 72,575 NA 270 million
Rehabilitation
(1 month)
61,688 200 260 million
Disability pension NA NA NA
Indirect costsb NA NA 530 million
Total 1,060
million
a Assuming 15% of patients die within 1 month after the event and
thus do not begin rehabilitation;
b Assuming the hypothesis of indirect costs being up to the double of
direct costs
NA, not applicable
Table 6 Overall estimated costs for the 80,804 hip fractures
registered in Italian elderly persons (≥65 years of age) in 2002
Patients, n Unit cost,
Euros
Cost
Hospitalization costs 80,804 NA 394 million
Rehabilitation
(1 month)
76,764a 5,375 412 million
Disability pension 18,000 6,000 108 million
Indirect costsb NA NA 161 million
Total 1,075
million
a Assuming 5% of patients died within 1 month of surgery and thus
not beginning rehabilitation;
b Based on 20% of direct costs (hospitalization and rehabilitation)
NA, not applicable
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Conclusion
This study shows that in the Italian adult population
(≥45 years) the number of hospitalizations following hip
fracture and AMI are comparable, while direct costs of
hospitalization following hip fracture were higher than
those for AMI and grew faster for all the 4 years examined.
These findings were based on a comparison of data issued
from a unique source and when applying similar methods
of analysis. This observation held when we focused on
elderly persons, as well as when we considered all adults
aged ≥45 years and thus included the age class with the
highest incidence of AMI (45–65 years). Therefore, hip
fractures in Italy are a serious medical problem and a
leading health cost driver, consistent with what has already
been reported for many other countries in the industrialized
world.
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